Effect of 4-demethoxydaunorubicin (4-DMDR) in chronic myeloid leukemia in blastic transformation and relapsed acute leukemias. 1985

G Bandini, and B Comotti, and G Scapoli, and F Leoni, and U Di Prisco, and L Mangoni, and R Battista, and S Tura

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003630 Daunorubicin A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS. Daunomycin,Rubidomycin,Rubomycin,Cerubidine,Dauno-Rubidomycine,Daunoblastin,Daunoblastine,Daunorubicin Hydrochloride,NSC-82151,Dauno Rubidomycine,Hydrochloride, Daunorubicin,NSC 82151,NSC82151
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias
D015255 Idarubicin An orally administered anthracycline antineoplastic. The compound has shown activity against BREAST NEOPLASMS; LYMPHOMA; and LEUKEMIA. 4-Demethoxydaunorubicin,4-Desmethoxydaunorubicin,IMI-30,Idarubicin Hydrochloride,NSC-256439,4 Demethoxydaunorubicin,4 Desmethoxydaunorubicin,Hydrochloride, Idarubicin,IMI 30,IMI30,NSC 256439,NSC256439

Related Publications

G Bandini, and B Comotti, and G Scapoli, and F Leoni, and U Di Prisco, and L Mangoni, and R Battista, and S Tura
January 1987, Haematology and blood transfusion,
G Bandini, and B Comotti, and G Scapoli, and F Leoni, and U Di Prisco, and L Mangoni, and R Battista, and S Tura
January 1984, Haematologica,
G Bandini, and B Comotti, and G Scapoli, and F Leoni, and U Di Prisco, and L Mangoni, and R Battista, and S Tura
March 1981, La Nouvelle presse medicale,
G Bandini, and B Comotti, and G Scapoli, and F Leoni, and U Di Prisco, and L Mangoni, and R Battista, and S Tura
January 1986, Cancer chemotherapy and pharmacology,
G Bandini, and B Comotti, and G Scapoli, and F Leoni, and U Di Prisco, and L Mangoni, and R Battista, and S Tura
May 1994, American journal of hematology,
G Bandini, and B Comotti, and G Scapoli, and F Leoni, and U Di Prisco, and L Mangoni, and R Battista, and S Tura
July 2010, The Journal of clinical investigation,
G Bandini, and B Comotti, and G Scapoli, and F Leoni, and U Di Prisco, and L Mangoni, and R Battista, and S Tura
April 1985, Cancer,
G Bandini, and B Comotti, and G Scapoli, and F Leoni, and U Di Prisco, and L Mangoni, and R Battista, and S Tura
August 1978, The Indian journal of medical research,
G Bandini, and B Comotti, and G Scapoli, and F Leoni, and U Di Prisco, and L Mangoni, and R Battista, and S Tura
January 1984, Indian journal of cancer,
G Bandini, and B Comotti, and G Scapoli, and F Leoni, and U Di Prisco, and L Mangoni, and R Battista, and S Tura
February 1975, Cancer,
Copied contents to your clipboard!